コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 xpressing myc epitope at the exofacial loop (GLUT4).
2 sponsive facilitative glucose transporter 4 (GLUT4).
3 ave a role in the specialized trafficking of GLUT4.
4 calization of Rab13 with ACTN4 or Rab13 with GLUT4.
5 ivo, concomitant with decreased abundance of GLUT4.
6 there is no three-dimensional structure for GLUT4.
7 ed receptor (PPAR) gamma target genes beyond Glut4.
8 location by interacting with IRAP as well as GLUT4.
9 the broader therapeutic utility of targeting GLUT4.
10 volve an increased cell surface abundance of GLUT4.
11 e proliferator-activated receptor gamma, and GLUT4.
12 y the major facilitative glucose transporter Glut4.
13 of the pathways from IR to translocation of GLUT4.
14 d glucose uptake and impaired endocytosis of GLUT4.
15 ous fat, and increased adipose expression of GLUT4.
18 xocytic translocation of vesicles containing GLUT4, a glucose transporter, and insulin-regulated amin
19 r significance for type 2 diabetes (in which GluT4 activity in the periphery is impaired) and Alzheim
22 in insulin signalling and glucose transport (GLUT4, Akt1 and Akt2) were unaffected by extended mornin
27 but decreases the stability of sortilin and Glut4 and blocks their entry into the small vesicular ca
31 on enhanced the translocation of GSV cargos, GLUT4 and insulin-regulated aminopeptidase (IRAP), and A
32 se included established GSV proteins such as GLUT4 and insulin-responsive aminopeptidase, as well as
33 on reduced TUG acetylation and redistributed GLUT4 and IRAP to the plasma membrane in 3T3-L1 adipocyt
34 that DHHC7 represents the principal PAT for Glut4 and that this mechanism is essential for insulin-r
35 pha2-macroglobulin receptor LRP1 cycles with Glut4 and the Tf receptor through all three exocytic pat
36 embrane and cytosolic domains from GLUT1 and GLUT4 and/or point mutations were generated and expresse
37 te markers, including glucose transporter 4 (GLUT4) and adiponectin expression and Oil Red O staining
38 ion of insulin-regulated glucose transporter GLUT4, and (iii) changed feedback from mammalian target
41 lin interacts with the first luminal loop of Glut4, and the cytoplasmic tail of sortilin binds to ret
42 proximately 32%) and repressed the levels of GLUT4 ( approximately 50%) in cultured myotubes from C57
43 in translocation of the glucose transporter GLUT4 are associated with peripheral insulin resistance,
44 ve terminals rely on the glucose transporter GLUT4 as a glycolytic regulatory system to meet the acti
45 we identify the insulin downstream effector GLUT4 as a key modulator of podocyte function in diabeti
50 ts importance, a selective knockout of brain GLUT4 (BG4KO) was generated by crossing Nestin-Cre mice
55 e activated by insulin in muscle to mobilize GLUT4-containing vesicles to the muscle cell surface.
57 contraction-induced increases in sarcolemmal GLUT4 content and glucose uptake were lower in the white
58 rapidly increased (p < 0.05) plasma membrane GLUT4 content in both red and white gastrocnemius muscle
59 ed pyruvate dehydrogenase activity, membrane GLUT4 content, and insulin-stimulated Akt phosphorylatio
61 This slow constitutive pathway is the only Glut4 cycling pathway in undifferentiated fibroblasts.
64 ce were decreased, indicating that increased GLUT4-dependent glucose flux decreases nutrient stress b
67 olism, suggesting the possibility that brain GluT4 dysregulation may be one cause of cognitive impair
69 re ubiquitously expressed in normal tissues, GLUT4 exhibits more limited normal expression profiles.
70 ly to a 62% decrease in the rate constant of Glut4 exocytosis (kex), although Rab10 knockdown also ca
74 5 mm glucose pulse increased adiponectin and GLUT4 expression and accumulation of neutral lipids via
75 ulin activation of glycogen synthase by 60%, GLUT4 expression by 16%, and 5' AMPK-alpha1 expression b
80 PPARgamma agonist rosiglitazone to increase Glut4 expression, but was not sufficient to increase exp
82 reasing the exocytic trafficking rate of the GLUT4 facilitative glucose transporter from intracellula
84 0 promote insulin-stimulated mobilization of GLUT4 from a perinuclear recycling endosome/TGN compartm
85 tes, sortilin together with retromer rescues Glut4 from degradation in lysosomes and retrieves it to
86 the translocation of the glucose transporter GLUT4 from intracellular vesicles to the cell surface.
89 Mice with a podocyte-specific deletion of GLUT4 (G4 KO) did not develop albuminuria despite having
90 mediated by glucose-dependent activation of GLUT4 gene transcription through the cis-acting GLUT4-li
91 nsgenic mice engineered to express the human GLUT4 gene under the control of the human GLUT4 promoter
95 r of insulin-stimulated translocation of the GLUT4 glucose transporter to the plasma membrane (PM) of
97 eavage liberates intracellularly sequestered GLUT4 glucose transporters for translocation to the cell
98 Insulin causes the exocytic translocation of GLUT4 glucose transporters to stimulate glucose uptake i
99 rs, CD36 (cluster of differentiation 36) and GLUT4 (glucose transporter type 4), are also unchanged.
100 ocytes appear to express glucose transporter GLUT4, glucose entry across the astrocyte plasma membran
102 e insulin signal transduction between IR and GLUT4 has been thoroughly studied with modeling and time
104 ied that determine steady state cell surface Glut4: (i) endocytosis, (ii) degradation, (iii) sorting,
105 el needed three distinct pathways from IR to GLUT4: (i) via protein kinase B (PKB) and Akt substrate
106 nexpectedly, whereas long-term inhibition of GluT4 impaired long-term memory, short-term memory was e
112 s results support a model in which TUG traps GLUT4 in intracellular, insulin-responsive vesicles term
116 ensing, indicating a critical role for brain GLUT4 in sensing and responding to changes in blood gluc
117 se that increased cell surface expression of GLUT4 in skeletal muscle and fatty tissue of AnkbR1788W/
118 d expression of IL-1 receptor antagonist and Glut4 in skeletal muscles after MSC transplantation resu
119 However, the role of insulin-responsive GLUT4 in the central nervous system has not been well ch
120 and also suggest differential regulation of GluT4 in the hippocampus from that in peripheral tissues
122 ts, the maintenance of elevated cell-surface GLUT4 in the presence of insulin requires accelerated bi
123 ent cell surface glucose transporter type 4 (GLUT4) in adipocytes resulting from impaired function of
125 evaluate the role of glucose transporter-4 (GLUT4) in the anti-diabetic effects of methanol, hexane
127 eletal muscle in vivo and ex vivo, increased GLUT4, increased ChREBP and markers of adipose tissue li
129 Inhibition of glucose metabolism with the GLUT4 inhibitor ritonavir elicits variable cytotoxicity
130 Activity at synapses triggers insertion of GLUT4 into the axonal plasma membrane driven by activati
131 ults in insertion of the glucose transporter GLUT4 into the plasma membrane and subsequent glucose up
134 sociated with glucose and lipid homeostasis (GLUT4, IRS1, FASN, ACACA, FATP2, CD36, and G6PC) in live
136 In the current study, we demonstrate that GluT4 is a critical component of hippocampal memory proc
137 gether, a moderate increase in expression of GLUT4 is a good target for treatment of insulin resistan
140 reviously determined that insulin-responsive GLUT4 is constitutively localized on the plasma membrane
143 Collectively, these results demonstrate that GLUT4 is not necessary for overload-induced muscle gluco
148 0 in GLUT1 to the corresponding positions in GLUT4 is sufficient to completely transform GLUT1 into G
149 The insulin-regulated glucose transporter-4 (GluT4) is critical for insulin- and contractile-mediated
151 growth were not impaired in muscle-specific GLUT4 knockout mice, demonstrating that GLUT4 is not nec
152 e adipose tissue (WAT) from adipose-specific Glut4-knockout or adipose-specific Glut4-overexpressing
153 urthermore, we show that genetic ablation of GLUT4 leads to an arrest of synaptic vesicle recycling d
154 d Akt, endothelial nitric oxide synthase and GLUT4 levels were also induced in hypertrophied muscles,
155 NA expression of glucose transporter type 4 (GLUT4), lipoprotein lipase (LpL), peroxisome proliferato
156 T4 gene transcription through the cis-acting GLUT4-liver X receptor element (LXRE) promoter element.
157 ail to restore normal lipid accumulation and GLUT4 localization in adipocytes are present in 1.3% of
158 ion, which was paralleled by increased basal GLUT4 localization in the sarcolemma, as assessed throug
160 60 substrates on the trafficking kinetics of Glut4, LRP1, and the Tf receptor were measured in adipoc
161 exists whereby other Gluts such as Glut3 and Glut4 may also support the influx of glucose into activa
162 te, selective intrahippocampal inhibition of GluT4-mediated glucose transport impaired memory acquisi
166 terization showed that PIMT was recruited to GLUT4, MEF2A and HDAC5 promoters and overexpression of P
168 T differentially regulated the expression of GLUT4, MEF2A, PGC-1alpha and HDAC5 in cultured cells and
170 its knockdown suppressed, insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes a
171 vation of DHHC7 suppressed insulin-dependent Glut4 membrane translocation in both 3T3-L1 adipocytes a
172 lmo2 is a new regulator of insulin-dependent Glut4 membrane translocation through modulating Rac1 act
173 c1 have been implicated in insulin dependent Glut4 membrane translocation, we hypothesize here that E
177 4 was due to both decreased transcription of Glut4 mRNA and decreased efficiency of Glut4 pre-mRNA sp
183 ription with an increase in the stability of Glut4 mRNA, resulting in opposing effects on steady-stat
189 ion to selectively remove basal hypothalamic Glut4 neurons and investigate the resulting phenotypes.
192 porters (Glut4) often colocalize in neurons (Glut4 neurons) in anatomically and functionally distinct
193 and insulin-responsive glucose transporters (Glut4) often colocalize in neurons (Glut4 neurons) in an
196 ural basis for the selectivity of PIs toward GLUT4 over GLUT1 that can be used in ongoing novel drug
197 -specific Glut4-knockout or adipose-specific Glut4-overexpressing mice with their respective controls
198 gain further insights into the regulation of Glut4 palmitoylation, we set out to identify the palmito
199 e that ectopic expression of DHHC7 increased Glut4 palmitoylation, whereas DHHC7 knockdown in 3T3-L1
201 mammalian DHHC proteins, DHHC7 is the major Glut4 PAT, based on evidence that ectopic expression of
202 l from endosomes may represent a step in the Glut4 pathway vulnerable to the development of insulin r
203 enes related to insulin sensitivity (ADIPOQ, GLUT4, PPARG2, and SIRT1) and lipogenesis (SREBP1c, ACC,
205 o potent compounds that were shown to target GLUT4 preferentially over GLUT1 and block glucose transp
206 an GLUT4 gene under the control of the human GLUT4 promoter (i.e., transgenic [TG] mice) are resistan
208 scued high-fat diet-induced decreased muscle GLUT4 protein and improved both fasting plasma insulin a
209 chanism regulated insulin-independent muscle GLUT4 protein expression in response to exercise in lean
213 -independent upregulation of skeletal muscle GLUT4 protein expression with exercise is through increa
215 RabGAP TBC1D1 plays a key role in regulating GLUT4 protein levels and in exercise-mediated glucose up
217 e and white adipose tissue, the abundance of GLUT4 protein, but not GLUT4 mRNA, was substantially red
221 lin stimulates proteolytic processing of the GLUT4 retention protein, TUG, to promote GLUT4 transloca
222 suggest that sortilin- and retromer-mediated Glut4 retrieval from endosomes may represent a step in t
223 s strongly bolster the utility of developing GLUT4-selective inhibitors as anti-cancer therapeutics.
225 ecialized intracellular compartments, termed GLUT4 storage vesicles (GSVs), to the plasma membrane.
228 Rab10 and RalA reside in the same pool of Glut4-storage vesicles in untreated cells, and, together
231 n triggers TUG cleavage to release the GSVs; GLUT4 then recycles through endosomes during ongoing ins
232 r of insulin-activated Rab13, which links to GLUT4 through ACTN4, localizing GLUT4 vesicles at the mu
234 ted for the signaling network between IR and GLUT4 to create a model also for their interconnections.
235 y sought to identify selective inhibitors of GLUT4 to develop a more potent cancer chemotherapeutic w
237 The active mTORC2 causes translocation of GLUT4 to the plasma membrane and glucose uptake without
241 of the insulin-regulated glucose transporter GLUT4 to the plasma membrane, where it sustains the ATP
245 dent translocation of glucose transporter 4 (Glut4) to the plasma membrane of fat and skeletal muscle
246 dent translocation of glucose transporter 4 (Glut4) to the plasma membrane plays a key role in the dy
250 rs of memory processing regulate hippocampal GluT4 trafficking and hippocampal memory formation is li
255 that VAMP2 is the major v-SNARE involved in GLUT4 trafficking to the surface of 3T3-L1 adipocytes.
257 These findings functionally link TUSC5 to GLUT4 trafficking, insulin action, insulin resistance, a
258 3B, and SEC31, in the insulin stimulation of GLUT4 trafficking, suggesting that vesicles derived from
260 ansport by regulating glucose transporter 4 (GLUT4) trafficking from specialized intracellular compar
261 erestingly, mathematical modeling shows that Glut4 traffics predominantly through the specialized Rab
263 letal muscle samples revealed that increased GLUT4 transgene expression was associated with decreased
264 ere, we show that, in male rats, hippocampal GluT4 translocates to the plasma membrane after memory t
265 e adiponectin administration-induced cardiac GLUT4 translocation and endothelial nitric oxide synthas
268 es in the absence of insulin by upregulating GLUT4 translocation by PI3K mediated activation of Akt s
270 ogenesis and elongation, glucose uptake, and GLUT4 translocation in cultured murine and human adipocy
271 D4 (AS160) were previously shown to regulate GLUT4 translocation in response to activation of AKT and
272 ncomplete disruption of stimulated adipocyte GLUT4 translocation on whole-body glucose homeostasis is
273 ive or negative regulators of the ISP, using GLUT4 translocation to the cell surface as an output for
274 a defect in one of the components regulating GLUT4 translocation to the cell surface in response to i
275 t both insulin-stimulated glucose uptake and GLUT4 translocation to the plasma membrane are reduced b
277 n signaling and effect on glucose uptake and Glut4 translocation were decreased, and lipolysis was in
278 uppressed insulin-stimulated glucose uptake, GLUT4 translocation, and Akt signaling in 3T3-L1 adipocy
280 red Rlf compensates for the loss of Rab10 in Glut4 translocation, suggesting that Rab10 recruits Rlf
287 campal blockade of glucose transport through GluT4-upregulated markers of hippocampal insulin signali
288 e C2-domain factor Doc2b plays a key role in GLUT4 vesicle fusion, but its molecular mechanism has be
289 ng triggers actin remodeling, which promotes GLUT4 vesicle translocation and glucose uptake into skel
292 and Rab13 is necessary for insulin-regulated GLUT4-vesicle exocytic translocation in muscle cells.
293 ich links to GLUT4 through ACTN4, localizing GLUT4 vesicles at the muscle cell periphery to enable th
294 cts with the motor protein MyoVa to mobilize GLUT4 vesicles toward the muscle cell plasma membrane.
297 ) was upregulated but glucose transporter 4 (GLUT4) was unaffected, and adipose triglyceride lipase (
298 ufficient to completely transform GLUT1 into GLUT4 with respect to indinavir inhibition of 2-DOG upta
299 le protein levels of the glucose transporter GLUT4, with increasing number of p.Arg684Ter alleles.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。